Bridging the gap of late gestation human nephrogenesis using a non-human primate model
Bridging the gap of late gestation human nephrogenesis using a non-human primate model
批准号:
10689659
负责人:
Meredith Schuh
金额:
$16.58万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-01 至 2025-08-31
关键词:
3-DimensionalATAC-seqAdultAdvisory CommitteesAgeAnatomyAnimalsAwardBinding SitesBioinformaticsBiological ModelsBirthCRISPR/Cas technologyCallithrixCallithrix jacchus jacchusCareer MobilityCell NucleusCellsChronic Kidney FailureCoupledDataData SetDevelopment PlansEnd stage renal failureEndowmentEnvironmentFetal KidneyFreezingFutureGene set enrichment analysisGenesGeneticGenetic TranscriptionGenomicsGestational AgeGoalsHealthHumanIn Situ HybridizationKidneyKidney DiseasesKnowledgeLateralLifeMacaca mulattaMapsMetanephric DiverticulumMethodsModelingMolecularMolecular BiologyMorphologyMusNephronsOutcomePathway interactionsPopulationPregnancyPremature BirthPremature InfantPrimatesProcessRNAResearchRhesusRiskSamplingSecond Pregnancy TrimesterSignal TransductionSystemTWIST1 geneTechnologyTestingTherapeuticTherapeutic InterventionThird Pregnancy TrimesterTissuesTrainingWith lateralityage relatedcareer developmentcell stromacertificate programcritical perioddruggable targetepigenomegene regulatory networkgenetic manipulationhigh riskimprovedlaboratory experiencelaser capture microdissectionmultiple omicsnephrogenesisnephron progenitornonhuman primatenovelperiviablepostnatalpostnatal periodprematurepreventsingle nucleus RNA-sequencingsingle-cell RNA sequencingstem cellstherapeutic developmenttranscription factortranscriptometranscriptome sequencingtranscriptomics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Premature infants have low nephron number (endowment) and are at high risk for chronic kidney disease (CKD)
and end stage renal disease as adults. Most nephrons are added late in gestation through a poorly understood
process called lateral branch nephrogenesis (LBN). As direct study of late gestation human kidney development
is difficult, the non-human primate model (rhesus macaque) was recently identified as a suitable model to bridge
this knowledge gap. The long-term goal is to apply the molecular findings of LBN in the non-human primate
model towards development of therapeutic methods aimed at extending nephrogenesis in preterm infants. The
central hypothesis is that a shift in the signaling milieu involving components of the developing kidney (nephron
progenitor cells (NPC), ureteric bud (UB), and stroma) results in sustaining LBN over multiple weeks in late
gestation. The rationale for this proposed research is that the genetically tractable non-human primate model
system can be used to test hypotheses and apply therapeutic interventions aimed at improving human nephron
endowment. The central hypothesis will be tested by using the latest molecular technologies to understand the
molecular mechanism sustaining LBN in the non-human primate, including single-cell RNA sequencing, laser
capture microdissection with RNA sequencing, single-nucleus RNA sequencing, and single-nucleus ATAC
sequencing. Preliminary morphologic study on the postnatal day two marmoset kidney identified a single ureteric
stalk with lateral branches consistent with LBN, suggesting the common marmoset could be used as a genetically
tractable primate model. Expected outcomes include assembly of the largest primate late gestation developing
kidney molecular dataset and identification of genes and pathways enriched and regulatory networks active
during LBN, as well as identification of a genetically tractable model to study LBN to understand why prematurity
leads to early cessation of nephrogenesis in humans, and how to extend it. These results are expected to have
a positive impact on the current understanding of late gestation human nephrogenesis by identifying molecular
pathways and potential therapeutic interventions for those born prematurely. In addition to the aims outlined in
this proposal, career development plans include didactic training in molecular biology and bioinformatics through
the Certificate program in Bioinformatics, wet-lab experience with the latest molecular technologies and multi-
omic platforms, and career advancement through a selected advisory committee for transition to independence
and submission of R01 during the K08 award period.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Human Nephrogenesis can Persist Beyond 40 Postnatal Days in Preterm Infants.
早产儿的人类肾发生可以持续 40 天以上。
DOI:
10.1016/j.ekir.2023.10.032
发表时间:
2024
期刊:
Kidney international reports
影响因子:
6
作者:
[Carpenter,James, Yarlagadda,Sunitha, VandenHeuvel,KatherineA, Ding,Lili, Schuh,MeredithP]
通讯作者:
Schuh,MeredithP
Bridging the gap of late gestation human nephrogenesis using a non-human primate model
-
批准号:10347725
-
项目类别:
-
资助金额:$16.73万
-
财政年份:2022
-
负责人:Meredith Schuh
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于ATAC-seq与DNA甲基化测序探究染色质可及性对莲两生态型地下茎适应性分化的作用机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
利用ATAC-seq联合RNA-seq分析TOP2A介导的HCC肿瘤细胞迁移侵
袭的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:柳静
-
依托单位:
面向图神经网络ATAC-seq模体识别的最小间隔单细胞聚类研究
-
批准号:62302218
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:张双全
-
依托单位:
基于ATAC-seq策略挖掘穿心莲基因组中调控穿心莲内酯合成的增强子
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:黄铭坤
-
依托单位:
基于单细胞ATAC-seq技术的C4光合调控分子机制研究
-
批准号:32100438
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:涂晓雨
-
依托单位:
基于ATAC-seq技术研究交叉反应物质197调控TFEB介导的自噬抑制子宫内膜异位症侵袭的分子机制
-
批准号:82001520
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:汤小晗
-
依托单位:
靶向治疗动态调控肺癌细胞DNA可接近性的ATAC-seq分析
-
批准号:81802809
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:蔡梅春
-
依托单位:
运用ATAC-seq技术分析染色质可接近性对犏牛初级精母细胞基因表达的调控作用
-
批准号:31802046
-
项目类别:青年科学基金项目
-
资助金额:27.0万元
-
批准年份:2018
-
负责人:张龚炜
-
依托单位:
基于ATAC-seq和RNA-seq研究CWIN调控采后番茄果实耐冷性作用机制
-
批准号:31801915
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2018
-
负责人:茹磊
-
依托单位:
基于ATAC-seq高精度预测染色质相互作用的新方法和基于增强现实的3D基因组数据可视化
-
批准号:31871331
-
项目类别:面上项目
-
资助金额:59.0万元
-
批准年份:2018
-
负责人:张治华
-
依托单位: